Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors
- Corey C. Foster
- , Marcus A. Couey
- , Sara E. Kochanny
- , Arun Khattri
- , Rajesh K. Acharya
- , Yi Hung Carol Tan
- , Ryan J. Brisson
- , Rom S. Leidner
- , Tanguy Y. Seiwert
Research output: Contribution to journal › Article › peer-review
77
Scopus
citations